Our studies show that although interleukin 4 (IL-4) fails to stimulate significant colony formation by bone marrow progenitor cells, it enhances erythroid, granulocyte, macrophage, and mast-cell colony formation when used as a costimulant with erythropoietin, granulocyte colony-stimulating factor, macrophage colony-stimulating factor, and interleukin 3 (IL-3), respectively. In contrast, IL-4 suppresses IL-3-dependent colony formation by granulocyte and macrophage progenitor cells and by multipotential progenitor cells.
Interleukin 4 (IL4), also known as B-cell stimulatory factor-1 (BSF-1), has been shown to possess stimulatory activities for mast-cell and T-cell lines as well as B cells (1) (2) (3) (4) . During the initial characterization of its mast-cell stimulatory activity, we showed that IL4 was capable of stimulating low levels of
[3H]thymidine incorporation by various mast-cell lines in short-term cultures (<48 hr) (1) . However, IL-4 itself does not sustain the long-term growth of these cell lines unless they are maintained at a high cell density (unpublished data). Under such conditions, their growth rate is extremely low compared to their growth rate in response to interleukin 3 (IL-3). We have also shown that IL4 synergistically enhances IL-3-dependent proliferation of various mast-cell lines in short-term and long-term cultures (1) . While it remains to be shown that IL4 functions as a primary hemopoietic growth factor, it does appear to have a strong costimulatory activity for mast-cell growth similar to its costimulatory activity for B-cell proliferation (5) .
The present studies describe the effects of IL4 on the clonal growth of natural bone marrow progenitor cells and on the development of early B-cell precursors in long-term lymphoid cultures. These studies focus on the stimulatory activities of IL4 when used alone or in combination with defined primary growth factors.
MATERIALS AND METHODS
Source of Factors. Erythropoietin (Epo) ( (9) , and lack surface immunoglobulin (10).
Immunofluorescent Staining. Bone marrow cells expressing low levels of Thy-1 and lacking various macrophage, granulocyte, T-cell, and B-cell markers (Thy-1i+, M-, G-, T-, B-) were prepared by fluorescence-activated cell sorting, as described (11) .
The nonadherent cells harvested from the Whitlock-Witte lymphoid cultures were analyzed for the expression of B220 antigen and surface IgM by fluorescence-activated cell sorting as described (11) .
RESULTS
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failed to stimulate colony formation by bone marrow progenitor cells in semisolid cultures. Results using 102 units/ml are shown in Fig. 1 . However, when IL-4 (102 units/ml) was used as a costimulant with Epo, there was a significant increase in the number of small erythroid colonies present on day 3 (derived from more mature progenitors, termed CFU-e) and an increase in the number of larger erythroid colonies present on day 7 (derived from more immature progenitors, termed BFU-e) (Fig. 1) . Similarly, the number and size of granulocyte colonies stimulated by G-CSF were enhanced by IL4 (Fig. 1) . In these experiments, the number of macrophage colonies stimulated by M-CSF was not significantly increased by costimulation with IL4, but there was a 2-to 3-fold increase in colony size. However, the ability of IL-4 to clearly increase the number of M-CSF-dependent colonies was observed under different experimental conditions (see below). Data presented in Fig. 1 are representative of three independent experiments. Given these assay conditions, enhancement of colony formation by IL4 was modest (2 times or less) but reproducible.
IL-4 Inhibits Progenitor Cell Growth Stimulated by IL-3.
IL-3 is referred to as a multi-CSF because it is a potent stimulator of multipotential progenitors as well as lineage committed progenitors at various stages of differentiation (12) . When suspension cultures of nonadherent bone marrow cells were stimulated with IL-3 in the presence of and absence of IL4, we found that the maximum number of cells produced in cultures containing IL-3 increased 15-fold, whereas the number of cells produced in cultures containing IL-3 plus IL4 increased only 3-fold (data not shown). Examination ofWright-Giemsa-stained cells from both types of cultures revealed maturing cells of all lineages, suggesting that IL4 inhibits cell proliferation but not cell differentiation. Following this preliminary observation, the effect of IL4 on individual colony-forming cells (CFCs) was assessed in methylcellulose cultures using bone marrow cells fractioned by fluorescence-activated cell sorting to enrich for progenitors that lack mature T cell, B cell, macrophage, and granulocyte markers, but express low levels of Thy-i antigen following stimulation with IL-3 ( Table 1 ). These Thy-110+ cells were unresponsive to IL-4 and responded poorly or not at all to G-CSF, M-CSF, or Epo using concentrations between 102 and 103 units/ml (data not shown). We found that the total number of colonies stimulated by IL-3 and Epo was decreased in the presence of IL-4 at 102 units/ml (Table 1) . The inhibitory activity of IL-4 was completely neutralized by a monoclonal antibody, liB11 (13) , which is specific for IL-4. In contrast, an isotype-matched antibody specific for an unrelated antigen had no effect (data not shown). These results indicate that the ability of IL-4 to inhibit colony formation by bone marrow cells is not due to a toxic substance acquired during purification and may not be dependent on the activities of mature accessory cells.
Cellular analysis of individual colonies (Table 1) suggests that costimulation with IL-4 caused a decrease by a factor of 2-3 in the absolute number of macrophage colonies and a small but reproducible decrease in the number of granulocyte and mixed colonies of two or more cell types. Furthermore, the number of colonies that attained a diameter of >0.3 mm by day 10 was greatly reduced in cultures containing IL-4 in addition to IL-3 ( Table 1 , numbers in parentheses). This finding suggests that many progenitor cells may initiate IL-3-dependent colony formation, but that the subsequent proliferation of their daughter cells is inhibited by IL-4. The negative effect of IL-4 on both the initiation and growth of colonies in semisolid cultures would account for the decrease by a factor of 5 in the number of cells produced in the liquid bone marrow cultures. Under the conditions of this assay, the development of mast cell and erythroid colonies, although low in numbers, did not appear to be affected by costimulation with IL-4. The finding that the combination of IL-4 and IL-3 did not cause an enhancement of erythrocyte growth above the level observed for IL-3 alone suggests that these two factors overlap in their ability to promote the development of erythrocyte colonies in response to erythropoietin.
The third plate from each type of culture was saved for observation following an additional week of incubation. We noted that in the culture containing both IL-3 and IL-4, a number of colonies continued to increase in size after the initial 10 days of culture. Several of these colonies were analyzed and found to consist of pure mast cells or mast cells mixed with other cell types. To follow up on this observation, new cultures were initiated with Thy-1l1+ cells and the development of mast cells was specifically studied over a prolonged incubation period. After 10 and 21 days of culture, the number and size of mast-cell colonies were evaluated. The numbers shown in Table 2 IL-3 was used at 400 units/ml and IL-4 was used at 100 units/ml. After 4 days of culture, Epo (1 unit/ml) was added to each plate to promote erythrocyte development. The activity of IL4 was completely blocked by 11B11 at 50 Ag/ml. Data in parentheses indicate number of colonies measuring >0.3 mm in diameter. G, neutrophilic granulocytes; M, macrophages; GM, mixed granulocytemacrophage; E, erythrocytes; Eo, eosinophilic granulocytes; Mast, mast cells; Mixed, mixture of two or more cell types excluding GM; ND, not done. *Mean ± SD of triplicate cultures scored on day 10. tValues reported are the absolute number of colonies sequentially picked from two plates and analyzed after treating with Wright-Giemsa stain.
pipetted to recover all of the cells and washed twice in plain medium. Various cell dilutions were then prepared and plated in semisolid cultures containing either Epo, G-CSF, M-CSF, or IL-3 (+Epo). In two independent experiments, we found that upon secondary stimulation with different CSFs, cells preincubated with IL-3 consistently formed more colonies of all lineages (Table 3 , column 1) than cells preincubated with IL-3 plus IL-4 (Table 3, column 2). Furthermore, cellular analysis of >400 individual colonies showed that cells preincubated in IL-3 without IL-4 also gave rise to more single and multilineage colonies when restimulated with IL-3 and Epo (data not shown). Thus, the IL-3-dependent regeneration of both multipotential and various monopotential CFCs appears to be inhibited in liquid bone marrow cultures containing IL-4. Although the total number of CFCs generated in the presence of IL-4 was lower, their growth pattern following restimulation with specific factors was similar to the growth pattern of CFCs generated in the absence of IL-4 (Table 3 ) and offresh bone marrow cells ( Fig. 1; Table 1 ). For example, both the size and number of erythrocyte colonies stimulated by Epo were enhanced in the presence of IL-4 whether bone marrow cells from (Table 3 , column 1) or IL-3 plus IL-4 (column 2) supplemented cultures were used as targets in the clonal assay. Identical effects on colony size and number were observed when G-CSF and M-CSF were used as primary stimulants. Furthermore, IL4 still generally suppressed IL-3-dependent colony formation by both target populations (columns 1 and 2). This result indicates that while IL4 suppresses the total number of CFCs generated in liquid cultures stimulated with IL-3, it does not select for CFCs with an increased or decreased sensitivity to restimulation with various CSFs and IL4. Furthermore, CFCs whose colony formation is enhanced by IL-4 plus Epo, G-CSF, or M-CSF are derived from CFCs whose IL-3-dependent proliferation is inhibited by IL-4. IL4 Inhibits Stromal Cell-Dependent Growth of Bone Marrow-Derived Pre-B Cells. The effect of IL-4 on the proliferation of pre-B cells was assessed in a long-term bone marrow culture system developed by Whitlock and Witte (7) . In these cultures, the growth and differentiation of early B-lineage cells are supported by an adherent layer of stromal cells. Pre-B cells are defined by a lymphoid appearance, absence of surface immunoglobulin, and expression of the B-cell-specific antigen, B220 (9) . We also determined the effect of IL-4 on the development of pre-B cells supported by a cloned stromal cell line, 30R. This fibroblast-like cell line is capable of supporting pre-B-cell growth similar to other stromal cell lines isolated from the adherent layer of Whitlock-Witte long-term bone marrow cultures (10, 14) . These other stromal cell lines and 30R also support limited growth ofgranulocytes Wright-Giemsa and a-naphthyl acetate esterase. They were also analyzed for expression of surface IgM (sIgM) and the B-cell-specific antigen B220. Cultures were fed biweekly with medium ± IL-4 (200 units/ml) during a 4-week period. Nonadherent cells removed during each medium change were replaced. BM, bone marrow; LTBMC, long-term bone marrow culture. *After 5 days of incubation, the number of discrete B cell colonies (consisting of >20 cells) was counted using a phase-contrast microscope with the aid of a transparent grid. The value reported is the mean ± SD of triplicate cultures grown in 35-mm dishes.
and macrophages. The data presented in Table 4 show that IL-4 suppresses the growth of pre-B cells in primary Whitlock-Witte cultures and in cultures consisting of a 30R monolayer seeded with nonadherent bone marrow cells from 3-week-old CBA/J mice. In each case, the number of nonadherent cells reported is an approximation of the total hemopoietic population present since many cells adhere to the stromal layer. After 4 weeks of culture, the low number of viable cells detected in IL-4 supplemented cultures consisted primarily of esterase-positive cells resembling macrophages. Furthermore, the adherent layer in IL-4 supplemented cultures was less dense than the control cultures and appeared devoid of hemopoietic cells that normally form clusters on top of the stromal cells.
To determine whether IL-4 affects the growth of pre-B cells directly, assays were performed with a stromal celldependent pre-B-cell line (B5). B5 cells give rise to discrete colonies within [5] [6] [7] days when low numbers are seeded onto a confluent monolayer of 30R cells (cloning efficiency, 10-15%). We found that the clonal growth of B5 cells was inhibited when added to 30R monolayers at the same time as IL-4 or when added to 30R monolayers preincubated in the presence of IL-4 for 48 hr (Table 4) . When llB11 antibodies were added with B5 cells to 30R monolayers preincubated with IL-4, the antiproliferative activity of IL-4 was blocked. This result suggests but does not prove that IL-4 may directly suppress the growth of the B5 pre-B cells and may not be due to some effect on the stromal cell population. This possibility is further supported by the fact that the 30R stromal cell monolayers did not show obvious morphological changes during the IL-4 treatment. Interestingly, B5 cells remained viable and could resume growth at the end of the 5-day assay period if IL-4 was removed by repeated medium changes (data not shown).
DISCUSSION
In the present study, the effect of IL-4 on the clonal growth of bone marrow progenitor cells was investigated. Although IL-4 alone was incapable of stimulating significant colony formation, it enhanced both the size and number of colonies formed by committed progenitor cells following stimulation with either Epo or G-CSF ( Fig. 1; Table 3 ). For reasons that are not understood, caused only a slight increase in the size of M-CSF-dependent macrophage colonies when the target population consisted of freshly isolated bone marrow cells (Fig. 1) . However, there was a dramatic enhancement in the size and number of macrophage colonies when we used bone marrow cells that had been prestimulated with IL-3 ( Table 3 ). These data indicate that IL-4 can synergize with Epo, G-CSF, and M-CSF to increase both the rate of cell growth and the number of CFCs that are responsive to these various CSFs.
Unexpectedly, IL-4 was found to inhibit the IL-3-dependent proliferation of certain multi-and monopotential progenitor cells (Table 1) . Some of the progenitor cells that are sensitive to negative regulation by IL-4 are the precursors of more mature CFCs whose proliferation is enhanced by IL-4 in combination with an appropriate primary stimulus (i.e., Epo, G-CSF, and M-CSF) ( Table 3 ). In addition, IL-4 did not significantly augment IL-3-dependent mast-cell colony formation in short-term assays even though it synergistically enhances the growth of IL-3-stimulated mast-cell lines (1) . Nevertheless, with prolonged incubation in the presence of IL-4, the number of mast cells within pure mast cell and mixed colonies continued to increase, whereas the continued growth of mast cells in cultures containing only IL-3 was not obvious (Table 2) . Mast cells are long lived and with the appropriate stimulus can proliferate after becoming mature (15) . Recently, it was reported that IL-4 is an essential costimulant for IL-3-dependent colony formation by mature resting connective tissue mast cells from the peritoneal cavity (15) . Our results with bone marrow-derived mast cells may be similar, in that IL-4 appears to signal mast cells within developing colonies to retain or increase their sensitivity to the mitogenic effects of IL-3.
The differential regulation ofprogenitor cell growth by IL-4 is apparently not specific to myeloid and erythroid lineages. Although IL-4 is a positive costimulator of mature resting B cells, we found that IL-4 inhibited the generation of pre-B cells in long-term lymphoid cultures and in bone marrow cultures established on an adherent stromal cell line. IL-4 also inhibited the clonal growth of a stromal cell-dependent pre-B-cell line, B5 (Table 4) . Because the viability of the B5 cells was not affected by IL-4, it appears that these early B cells simply become unresponsive to the mitogenic activity produced by the stromal cells (10) .
Based on our studies, IL-4 appears to have diverse regulatory actions. One explanation for these activities is that progenitor cells at different stages of maturation respond differently to IL-4. For example, IL-3 responsive populations contain both primitive and more mature progenitor cells, 6892 Immunology: Rennick et al.
whereas most G-CSF, M-CSF, and Epo responsive cells are the more mature lineage restricted types. The ability of IL-4 to inhibit some but not all IL-3 dependent colony formation may be directed at immature progenitor cells that are more sensitive to negative regulation by IL-4. However, our data are also consistent with the possibility that inhibition versus enhancement of progenitor cell growth is determined by the particular combination of stimuli acting on a given cell. Thus, IL-4 may augment the mitogenic effects of M-CSF, G-CSF, or Epo but antagonize many of the mitogenic effects of IL-3 and a pre-B-cell factor. A similar mechanism of action has been proposed for transforming growth factor type B, which stimulates the growth of fibroblasts in soft agar in the presence of platelet-derived growth factor, while it inhibits their growth in the presence of epidermal growth factor (16) .
The cellular mechanisms involved in the ability of IL-4 to regulate both positive and negative aspects of myeloid and B-cell development are likely to be complex and remain to be defined. Recently, it was suggested that IL-4 may function as a progression or a cocompetence factor in the stimulation of mature resting B cells (17) . Our observation that IL-4 enhances the proliferation of various committed progenitor cells to lineage restricted CSFs agrees with these studies. In this context, however, our data further suggest that when IL-4 actsjointly with specific early acting growth factors (i.e., IL-3 and a stromal cell-derived pre-B-cell growth factor), it blocks the progression of immature myeloid and B-cell progenitors at some stage in the cell cycle. Another possibility is that IL-4 influences the continued expression of a receptor for a given factor at some critical level or influences (accelerates) the sequential loss and acquisition of receptors for specific early and late acting growth factors, respectively. Receptor modulation could account for the effects IL-4 has on the factor-dependent growth ofprimitive and more mature progenitor cells described here. This interpretation is consistent with other studies showing that IL-4 regulates the expression of its own receptor (17) and the expression of Fce receptors (18) on B cells.
The mechanisms discussed above presume that IL-4 is acting directly at the progenitor cell level. It is possible that some of the regulatory effects of IL-4 are mediated through secondary interactions. The bone marrow populations used for some of our clonal assays and for long-term pre-B-cell cultures contained accessory cells. The rapid generation of accessory cells cannot be avoided even in the clonal assays that were initiated with highly purified Thy-1Io+ progenitor cells. Nevertheless, our data support and extend information concerning the ability of IL-4 to directly or indirectly influence the cellular nature of an immune response. In this regard, IL-4 may be instrumental in preventing the excessive clonal expansion of relatively immature progenitor cells in peripheral organs while at the same time selectively increasing the responsiveness of more mature lymphoid, myeloid, and erythroid progenitor cells to various growth and differentiation signals. Because of these diverse activities, careful evaluation will be necessary to establish the potential use of IL-4 in different clinical settings.
